Literature DB >> 30195841

Pulmonary hypertension in adults with congenital heart disease: Updated recommendations from the Cologne Consensus Conference 2018.

Harald Kaemmerer1, Christian Apitz2, Konrad Brockmeier3, Andreas Eicken4, Matthias Gorenflo5, Alfred Hager4, Fokko de Haan6, Michael Huntgeburth7, Rainer G Kozlik-Feldmann8, Oliver Miera9, Gerhard P Diller10.   

Abstract

In the summer of 2016, delegates from the German Respiratory Society (DGP), the German Society of Cardiology (DGK) and the German Society of Pediatric Cardiology (DGPK) met in Cologne, Germany, to define consensus-based practice recommendations for the management of patients with pulmonary hypertension (PH). These recommendations were built on the 2015 European Pulmonary Hypertension guidelines, aiming at their practical implementation, considering country-specific issues, and including new evidence, where available. To this end, a number of working groups was initiated, one of which was specifically dedicated to PH in adults associated with congenital heart disease (CHD). As such patients are often complex and require special attention, and the general PAH treatment algorithm in the ESC/ERS guidelines appears too unspecific for CHD, the working group proposes an analogous algorithm for the management of PH-CHD which takes the special features of this patient group into consideration, and includes general measures, supportive therapy, targeted PAH drug therapy as well as interventional and surgical procedures. The detailed results and recommendations of the working group on PH in adults with CHD, which were last updated in the spring of 2018, are summarized in this article.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adult; Congenital heart disease; Medical therapy; Pulmonary hypertension; Shunt

Mesh:

Year:  2018        PMID: 30195841     DOI: 10.1016/j.ijcard.2018.08.078

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part II: infective endocarditis, pulmonary hypertension, pulmonary arterial hypertension and aortopathy.

Authors:  Rhoia Neidenbach; Koichiro Niwa; Oeztekin Oto; Erwin Oechslin; Jamil Aboulhosn; David Celermajer; Joerg Schelling; Lars Pieper; Linda Sanftenberg; Renate Oberhoffer; Fokko de Haan; Michael Weyand; Stephan Achenbach; Christian Schlensak; Dirk Lossnitzer; Nicole Nagdyman; Yskert von Kodolitsch; Hans-Carlo Kallfelz; David Pittrow; Ulrike M M Bauer; Peter Ewert; Thomas Meinertz; Harald Kaemmerer
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

Review 2.  Thromboembolic complications in adult congenital heart disease: the knowns and the unknowns.

Authors:  Magalie Ladouceur; Clément Karsenty; Victor Waldmann; Barbara Mulder; Sébastien Hascoet
Journal:  Clin Res Cardiol       Date:  2020-10-09       Impact factor: 5.460

3.  Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.

Authors:  Christian Opitz; Ekkehard Grünig; Stephan Rosenkranz; Ann-Sophie Kaemmerer; Matthias Gorenflo; Dörte Huscher; David Pittrow; Peter Ewert; Christine Pausch; Marion Delcroix; Hossein A Ghofrani; Marius M Hoeper; Rainer Kozlik-Feldmann; Andris Skride; Gerd Stähler; Carmine Dario Vizza; Elena Jureviciene; Dovile Jancauskaite; Lina Gumbiene; Ralf Ewert; Ingo Dähnert; Matthias Held; Michael Halank; Dirk Skowasch; Hans Klose; Heinrike Wilkens; Katrin Milger; Christian Jux; Martin Koestenberger; Laura Scelsi; Eva Brunnemer; Michael Hofbeck; Silvia Ulrich; Anton Vonk Noordegraaf; Tobias J Lange; Leonhard Bruch; Stavros Konstantinides; Martin Claussen; Judith Löffler-Ragg; Hubert Wirtz; Christian Apitz; Rhoia Neidenbach; Sebastian Freilinger; Attila Nemes
Journal:  Cardiovasc Diagn Ther       Date:  2021-12

Review 4.  Haemoptysis in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: Insights on Pathophysiology, Diagnosis and Management.

Authors:  Amalia Baroutidou; Alexandra Arvanitaki; Adam Hatzidakis; Georgia Pitsiou; Antonios Ziakas; Haralambos Karvounis; George Giannakoulas
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

5.  Maternal and fetal outcomes of pregnant women with pulmonary arterial hypertension associated with congenital heart disease in Beijing, China: A retrospective study.

Authors:  Yang Liu; Yanna Li; Jun Zhang; Dawei Zhang; Jiachen Li; Yichen Zhao; Kemin Liu; Xiaolong Ma; Chen Bai; Hong Gu; Xiangming Fan; Jiangang Wang
Journal:  Pulm Circ       Date:  2022-04-22       Impact factor: 2.886

6.  Long-Term Survival of Adult Patients With Atrial Septal Defect With Regards to Defect Closure and Pulmonary Hypertension.

Authors:  Jana Rubáčková Popelová; Markéta Tomková; Jakub Tomek; Renata Živná
Journal:  Front Cardiovasc Med       Date:  2022-04-28

Review 7.  Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.

Authors:  Carlos Daniel Varela-Chinchilla; Daniela Edith Sánchez-Mejía; Plinio A Trinidad-Calderón
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-26

8.  The Treatment Strategy for the Atrial Septal Defect in the Presence of Severe Pulmonary Hypertension.

Authors:  Evelina Zarambaitė; Grytė Ramantauskaitė; Aušra Krivickienė; Adakrius Siudikas; Skaidrius Miliauskas; Eglė Ereminienė
Journal:  Medicina (Kaunas)       Date:  2022-07-02       Impact factor: 2.948

9.  Spontaneous Closure of Perimembranous Ventricular Septal Defects: A Janus-Faced Condition.

Authors:  Peter Bride; Michael Kaestner; Michael Radermacher; Keti Vitanova; Fabian von Scheidt; Dominik Scharnbeck; Christian Apitz
Journal:  CASE (Phila)       Date:  2019-10-07

10.  Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.

Authors:  Harald Kaemmerer; Matthias Gorenflo; Dörte Huscher; David Pittrow; Christian Apitz; Helmut Baumgartner; Felix Berger; Leonhard Bruch; Eva Brunnemer; Werner Budts; Martin Claussen; Gerry Coghlan; Ingo Dähnert; Michele D'Alto; Marion Delcroix; Oliver Distler; Sven Dittrich; Daniel Dumitrescu; Ralf Ewert; Martin Faehling; Ingo Germund; Hossein Ardeschir Ghofrani; Christian Grohé; Karsten Grossekreymborg; Michael Halank; Georg Hansmann; Dominik Harzheim; Attila Nemes; Kalman Havasi; Matthias Held; Marius M Hoeper; Michael Hofbeck; Wolfgang Hohenfrost-Schmidt; Elena Jurevičienė; Lina Gumbienè; Hans-Joachim Kabitz; Hans Klose; Thomas Köhler; Stavros Konstantinides; Martin Köestenberger; Rainer Kozlik-Feldmann; Hans-Heiner Kramer; Cornelia Kropf-Sanchen; Astrid Lammers; Tobias Lange; Philipp Meyn; Oliver Miera; Katrin Milger-Kneidinger; Rhoia Neidenbach; Claus Neurohr; Christian Opitz; Christian Perings; Bjoern Andrew Remppis; Gabriele Riemekasten; Laura Scelsi; Werner Scholtz; Iveta Simkova; Dirk Skowasch; Andris Skride; Gerd Stähler; Brigitte Stiller; Iraklis Tsangaris; Carmine Dario Vizza; Anton Vonk Noordegraaf; Heinrike Wilkens; Hubert Wirtz; Gerhard-Paul Diller; Ekkehard Grünig; Stephan Rosenkranz
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.